Clinical trial
Intracoronary Administration of Levosimendan in Cardiac Surgery Patients
NCT01500785 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intracoronary Administration of Levosimendan in Cardiac Surgery Patients
- Lead sponsor
- Tampere University Hospital
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 15, 2018
- Completion date
- September 11, 2019
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.